Evidence map›Paper›PMID 39324245›Full record

ArticleBJPsych open2024

Effect of strength-based physical exercise on telomere length as a marker of premature ageing in patients with schizophrenia: study protocol for a pilot randomised controlled trial.

Juan Luis Sánchez-González, Raúl Juárez-Vela, Virginia Dutil Muñoz de la Torre, María Del Pilar Andrés-Olivera, Javier Martín-Vallejo, Álvaro Morán-Bayón, Joana Isabel Gonçalves-Cerejeira, Nerea Gestoso-Uzal, Rogelio González-Sarmiento, Jesús Pérez

Abstract read
In one paragraph

Article in BJPsych open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Juan Luis Sánchez-GonzálezDepartment of Nursing and Physiotherapy, University of Salamanca, Spain; and Department of Neuroscience, Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.ORCID https://orcid.org/0000-0002-4791-6513
Raúl Juárez-VelaFaculty of Health Sciences, University of La Rioja, Logroño, Spain; and Department of Neuroscience, Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Virginia Dutil Muñoz de la TorrePsychiatry Service, Salamanca Health Care Complex, Salamanca, Spain.ORCID https://orcid.org/0000-0002-4720-2406
María Del Pilar Andrés-OliveraPsychiatry Service, Salamanca Health Care Complex, Salamanca, Spain.ORCID https://orcid.org/0000-0002-0904-788X
Javier Martín-VallejoDepartment of Statistics, University of Salamanca, Spain.ORCID https://orcid.org/0000-0003-3962-7356
Álvaro Morán-BayónDepartment of Medicine, University of Salamanca, Spain; and Department of Neuroscience, Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.ORCID https://orcid.org/0000-0001-9695-4789
Joana Isabel Gonçalves-CerejeiraPsychiatry Service, Avila Health Care Complex, Avila, Spain.ORCID https://orcid.org/0000-0002-2739-800X
Nerea Gestoso-UzalDepartment of Molecular Medicine, Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.ORCID https://orcid.org/0000-0002-9755-6739
Rogelio González-SarmientoDepartment of Medicine, University of Salamanca, Spain; and Department of Molecular Medicine, Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.ORCID https://orcid.org/0000-0002-2726-6795
Jesús PérezDepartment of Medicine, University of Salamanca, Spain; Department of Neuroscience, Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Department of Psychiatry, University of Cambridge, UK; and Norwich Medical School, University of East Anglia, Norwich, UK.ORCID https://orcid.org/0000-0003-0740-190X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with schizophrenia die decades earlier than the general population. Among the factors involved in this mortality gap, evidence suggests a telomere length shortening in this clinical population, which is associated with premature ageing. Recent studies support the use of strength-based training exercise programmes to maintain, or even elongate, telomere length in healthy elderly populations. However, studies aiming at modifying telomere length in severe mental illnesses, such as schizophrenia, are still very scarce.

aimsTo investigate the effect of a strength-based physical exercise programme on the telomere length of individuals with schizophrenia.

methodWe propose a pragmatic, randomised controlled trial including 40 patients aged ≥18 years, with a stable diagnosis of schizophrenia, attending the Complejo de Rehabilitación Psicosocial (CRPS, Psychosocial Rehabilitation Centre) in Salamanca, Spain. These patients will be randomly assigned (1:1) to either receive the usual treatment and rehabilitation programmes offered by CRPS (treatment-as-usual group) or these plus twice weekly sessions of an evidence-based, strength-based training exercise programme for 12 weeks (intervention group). The primary outcome will be effect on telomere length. Secondary outcomes will include impact on cognitive function, frailty and quality of life.

resultsWe expect to show the importance of implementing strength-based physical exercise programmes for patients with schizophrenia. We could find that such programmes induce biological and genetic changes that may lengthen life expectancy and decrease physical fragility.

conclusionsWe anticipate that our trial findings could contribute to parity of esteem for mental health, reducing premature ageing in patients with severe mental illnesses, such as schizophrenia.

Indexed as

Ageingexercisemortalityschizophreniatelomere

Identifiers

PMID39324245
PMCPMC11457242

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.